CTI BioPharma is a Seattle-based biopharmaceutical company with dedicated and committed employees who look at the development of potential therapies from a patient’s perspective to address both the unmet medical need and the impact treatment can have on a patient’s life. Our mission is to acquire, develop and bring to market less toxic, more effective therapies to treat and cure cancer. Our therapeutic focus is on novel, targeted therapies covering a spectrum of blood-related cancers.
At CTI, we recognize that living with cancer requires more than just discovering breakthrough cancer treatments and that’s why we partner with Gilda’s Club Seattle. We are very fortunate to have this great support system in our community.learn more